Lee’s Pharmaceutical saw no growth in patent filings in April and highest growth of 0.99% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Lee’s Pharmaceutical’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Lee's Pharmaceutical has been focused on protecting inventions in China(CN) with two publications in Q2 2024
The China(CN) Patent Office dominates the patent grants with nearly 67% of grants. The World Intellectual Property Organization(WIPO), China(CN), and South Korea(KR) patent Office are among the top ten patent offices where Lee's Pharmaceutical is filings its patents. Among the top granted patent authorities, Lee's Pharmaceutical has 67% of its grants in China(CN) and 33% in South Korea(KR).
Amgen could be the strongest competitor for Lee's Pharmaceutical
Lee's Pharmaceutical stands in second position with respect to its patent publications among its competitors.
Patents related to climate change lead Lee's Pharmaceutical's portfolio
Lee's Pharmaceutical has the highest number of patents in climate change. For climate change no patents were filed and 100% of patents were granted in Q2 2024.
Anemia related patents lead Lee's Pharmaceutical portfolio
Lee's Pharmaceutical has highest number of patents in anemia.
For comprehensive analysis of Lee's Pharmaceutical's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
